Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Non-Current Assets readings, the most recent being $58.5 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 5.09% to $58.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $232.4 million, a 5.21% increase, with the full-year FY2025 number at $58.5 million, up 5.09% from a year prior.
  • Non-Current Assets hit $58.5 million in Q4 2025 for Treace Medical Concepts, roughly flat from $58.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $58.8 million in Q2 2025 to a low of $929000.0 in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $52.4 million (2023), compared with a mean of $37.1 million.
  • Biggest five-year swings in Non-Current Assets: soared 1966.63% in 2022 and later grew 1.95% in 2025.
  • Treace Medical Concepts' Non-Current Assets stood at $2.8 million in 2021, then skyrocketed by 799.33% to $25.6 million in 2022, then surged by 108.99% to $53.5 million in 2023, then grew by 4.0% to $55.7 million in 2024, then increased by 5.09% to $58.5 million in 2025.
  • The last three reported values for Non-Current Assets were $58.5 million (Q4 2025), $58.6 million (Q3 2025), and $58.8 million (Q2 2025) per Business Quant data.